|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 4 (August 15), 1999:
pp. 1440-1450
Proteolytic Processing of Big Endothelin-3 by the Kell Blood Group
Protein
Soohee Lee,
Melissa Lin,
Aldo Mele,
Ying Cao,
James Farmar,
David Russo, and
Colvin Redman
From The Lindsley F. Kimball Research Institute of the New York Blood
Center, New York, NY.
Kell blood group protein shares a consensus sequence (H.E.X.X.H)
with a large family of zinc-dependent endopeptidases. Kell has closest
homology with neutral endopeptidase 24.11, endothelin converting
enzyme-1 (ECE-1), and the PEX gene product that, as a group,
comprise the M13 subfamily of mammalian neutral endopeptidases. The
proteolytic activity of the M13 members, but not of Kell, has been
previously demonstrated. A secreted form of wild-type Kell protein
(s-Kell), devoid of the intracellular and transmembrane domains, was
expressed in sf9 cells. As a negative control, an inactive mutant Kell
protein (E582G) was expressed. As determined by N-terminal amino acid
sequencing and mass spectrometry of the cleaved products, wild-type
s-Kell, but not the control mutant protein, specifically cleaved big
endothelin-3 (ET-3) at Trp21-Ile22, yielding
ET-3, and, to a much lesser extent, also cleaved big ET-1 and big ET-2
at Trp21-Val22, yielding ET-1 and ET-2.
Enzymatic activity was partially inhibited by phosphoramidon. s-Kell
has an acidic pH optimum (pH 6.0 to 6.5). Like the recombinant protein,
red blood cells of common Kell phenotype also preferentially process
big ET-3, in contrast to Ko (null) cells that do not. These data
demonstrate that the Kell blood group protein is a proteolytic enzyme
that processes big ET-3, generating ET-3, a potent bioactive peptide
with multiple biological roles.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. Chen, J. Liu, S. Heck, J. A. Chasis, X. An, and N. Mohandas
Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis
PNAS,
October 13, 2009;
106(41):
17413 - 17418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Salomao, X. Zhang, Y. Yang, S. Lee, J. H. Hartwig, J. A. Chasis, N. Mohandas, and X. An
Protein 4.1R-dependent multiprotein complex: New insights into the structural organization of the red blood cell membrane
PNAS,
June 10, 2008;
105(23):
8026 - 8031.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lee, Q. Sha, X. Wu, G. Calenda, and J. Peng
Expression Profiles of Mouse Kell, XK, and XPLAC mRNA
J. Histochem. Cytochem.,
April 1, 2007;
55(4):
365 - 374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Walker, H. H. Jung, C. Dobson-Stone, L. Rampoldi, A. Sano, F. Tison, and A. Danek
Neurologic phenotypes associated with acanthocytosis
Neurology,
January 9, 2007;
68(2):
92 - 98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Sha, C. M. Redman, and S. Lee
Endothelin-3-converting Enzyme Activity of the KEL1 and KEL6 Phenotypes of the Kell Blood Group System
J. Biol. Chem.,
March 17, 2006;
281(11):
7180 - 7182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Claperon, C. Rose, P. Gane, E. Collec, O. Bertrand, and T. Ouimet
The Kell Protein of the Common K2 Phenotype Is a Catalytically Active Metalloprotease, whereas the Rare Kell K1 Antigen Is Inactive: IDENTIFICATION OF NOVEL SUBSTRATES FOR THE KELL PROTEIN
J. Biol. Chem.,
June 3, 2005;
280(22):
21272 - 21283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S.N. Rowe
THE WRICKKENED PATHWAYS OF FGF23, MEPE AND PHEX
Critical Reviews in Oral Biology & Medicine,
September 1, 2004;
15(5):
264 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lee, A. K. Debnath, and C. M. Redman
Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11
Blood,
October 15, 2003;
102(8):
3028 - 3034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Garratty, M. J. Telen, and L. D. Petz
Red Cell Antigens as Functional Molecules and Obstacles to Transfusion
Hematology,
January 1, 2002;
2002(1):
445 - 462.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. Bur, G. E. Dale, and C. Oefner
A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP)
Protein Eng. Des. Sel.,
May 1, 2001;
14(5):
337 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Russo, X. Wu, C. M. Redman, and S. Lee
Expression of Kell blood group protein in nonerythroid tissues
Blood,
July 1, 2000;
96(1):
340 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Shirotani, S. Tsubuki, N. Iwata, Y. Takaki, W. Harigaya, K. Maruyama, S. Kiryu-Seo, H. Kiyama, H. Iwata, T. Tomita, et al.
Neprilysin Degrades Both Amyloid beta Peptides 1-40 and 1-42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive Endopeptidases
J. Biol. Chem.,
June 8, 2001;
276(24):
21895 - 21901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-C. Yu, Y.-C. Twu, C.-Y. Chang, and M. Lin
Molecular Basis of the Kell-null Phenotype. A MUTATION AT THE SPLICE SITE OF HUMAN KEL GENE ABOLISHES THE EXPRESSION OF KELL BLOOD GROUP ANTIGENS
J. Biol. Chem.,
March 23, 2001;
276(13):
10247 - 10252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Raharjo, N. Emoto, K. Ikeda, R. Sato, M. Yokoyama, and M. Matsuo
Alternative Splicing Regulates the Endoplasmic Reticulum Localization or Secretion of Soluble Secreted Endopeptidase
J. Biol. Chem.,
June 29, 2001;
276(27):
25612 - 25620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lee, D. C. W. Russo, A. P. Reiner, J. H. Lee, M. Y. Sy, M. J. Telen, W. J. Judd, P. Simon, M. J. Rodrigues, T. Chabert, et al.
Molecular Defects Underlying the Kell Null Phenotype
J. Biol. Chem.,
July 13, 2001;
276(29):
27281 - 27289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
